Cargando…
A Two-Dose Oritavancin Regimen Using Pharmacokinetic Estimation Analysis
BACKGROUND: Antibiotics for the treatment of complicated, multidrug-resistant Gram-positive infections are limited, especially when prolonged treatment is necessary. Oritavancin is approved for the treatment of serious skin infections as a 1200 mg single-dose regimen, but case reports describe suppl...
| Autores principales: | , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Springer International Publishing
2020
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7334312/ https://www.ncbi.nlm.nih.gov/pubmed/32588386 http://dx.doi.org/10.1007/s40801-020-00188-6 |